$0.0137
-0.0063[-31.50%]
At close: Apr 26
Sorrento Therapeutics
(OTCEM:SRNE)Sorrento Therapeutics Stock (OTC:SRNE), Earnings Estimates, EPS, and Revenue
Sorrento Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 8
EPS
$-0.200
Quarterly Revenue
$17.4M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$64.3M
Analyze the earnings history of Sorrento Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/08/2022 | AM | SRNE | Q3 | -$0.40 | — | -$0.20 | — | $12.06M | — | $17.40M | — | Get Alert |
| 08/15/2022 | AM | SRNE | Q2 | -$0.57 | — | -$0.54 | — | $13.51M | — | $11.46M | — | Get Alert |
| 05/06/2022 | AM | SRNE | Q1 | $0.01 | — | -$0.12 | — | $14.26M | — | $18.39M | — | Get Alert |
| 03/11/2022 | AM | SRNE | Q4 | -$0.25 | — | -$0.47 | — | $11.51M | — | $13.08M | — | Get Alert |
| 11/05/2021 | AM | SRNE | Q3 | -$0.33 | -$0.21 | -$0.40 | -90.48% | $11.75M | $10.21M | $12.06M | 18.14% | Get Alert |
| 08/06/2021 | PM | SRNE | Q2 | -$0.36 | -$0.20 | -$0.57 | -185.00% | $9.01M | $10.13M | $13.51M | 33.38% | Get Alert |
| 05/05/2021 | PM | SRNE | Q1 | -$0.36 | $0.24 | $0.01 | -95.83% | $7.72M | $17.25M | $14.26M | -17.36% | Get Alert |
| 02/19/2021 | AM | SRNE | Q4 | -$0.41 | — | -$0.25 | — | $13.03M | — | $11.51M | — | Get Alert |
| 11/09/2020 | AM | SRNE | Q3 | -$0.50 | — | -$0.33 | — | $5.78M | — | $11.75M | — | Get Alert |
| 08/04/2020 | AM | SRNE | Q2 | -$0.47 | -$0.24 | -$0.36 | -50.00% | $6.48M | $7.90M | $9.01M | 14.01% | Get Alert |
| 05/11/2020 | AM | SRNE | Q1 | -$0.88 | -$0.20 | -$0.36 | -80.00% | $6.14M | $10.00M | $7.72M | -22.79% | Get Alert |
| 03/03/2020 | AM | SRNE | Q4 | -$0.41 | — | -$0.41 | — | $6.93M | — | $13.03M | — | Get Alert |
| 11/12/2019 | AM | SRNE | Q3 | -$0.40 | -$0.38 | -$0.50 | -31.58% | $4.11M | $7.40M | $5.78M | -21.92% | Get Alert |
| 08/09/2019 | AM | SRNE | Q2 | -$0.73 | -$0.36 | -$0.47 | -30.56% | $3.91M | $7.65M | $6.48M | -15.33% | Get Alert |
| 05/14/2019 | AM | SRNE | Q1 | -$0.38 | -$0.34 | -$0.88 | -158.82% | $6.25M | $9.31M | $6.14M | -34.02% | Get Alert |
FAQ
When is Sorrento Therapeutics (OTCEM:SRNE) reporting earnings?
Sorrento Therapeutics (SRNE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2022 for Q3.
What were the latest earnings per share (EPS) for Sorrento Therapeutics (OTCEM:SRNE)?
Sorrento Therapeutics (SRNE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2022 for Q3 and the Actual EPS was $-0.20, which missed the estimate of $0.00.
What were Sorrento Therapeutics’s (OTCEM:SRNE) revenues?
Sorrento Therapeutics (SRNE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2022 for Q3 and the Actual Revenue was $17.4M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.